Crescent Capital Bdc, Inc. (CCAP)
NASDAQ:CCAP
Want to see CCAP full AI Analyst Report?
CCAP Stock Chart & Stats
$13.58
-$0.14(-0.74%)
At close: 4:00 PM EST
$13.58
-$0.14(-0.74%)
Day’s Range― - ―
52-Week Range$10.92 - $16.04
Previous CloseN/A
Volume41.80K
Average Volume (3M)230.13K
Market Cap
$414.89M
Enterprise Value$1.30B
Total Cash (Recent Filing)$54.19M
Total Debt (Recent Filing)$907.13M
Price to Earnings (P/E)27.5
Beta0.60
Next Earnings
Aug 12, 2026EPS Estimate
0.37Next Dividend Ex-DateN/A
Dividend Yield13.2%
Share Statistics
EPS (TTM)0.41
Shares Outstanding36,845,950
10 Day Avg. Volume197,633
30 Day Avg. Volume230,133
Financial Highlights & Ratios
PEG Ratio-0.28
Price to Book (P/B)0.74
Price to Sales (P/S)3.33
P/FCF Ratio6.97
Enterprise Value/Market Cap3.14
Enterprise Value/Revenue10.43
Enterprise Value/Gross Profit15.59
Enterprise Value/Ebitda25.50
Forecast
1Y Price Target
$14.08Price Target Upside3.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)1.56
Revenue Forecast (FY)$149.99M
Bulls Say, Bears Say
Bulls Say
Consistent Cash GenerationCCAP exhibits durable cash generation: operating cash flow has been consistently positive and free cash flow has historically matched OCF and net income. That steady cash conversion supports dividend coverage, deleveraging or reinvestment and underpins long-term distributable earnings resilience.
Permanent Fee Structure ReductionManagement’s permanent reduction in base and incentive fees materially lowers ongoing expense drag versus peers, improving long-run earnings consistency and reducing sensitivity of distributable cashflows to volatile incentive income. This structural action aligns incentives and supports more predictable NII over time.
Improved Liquidity And Diversified FundingCCAP has strengthened its funding mix and liquidity profile via facility expansion, new unsecured notes and available capacity. A larger committed facility and diversified debt maturities reduce rollover risk and give management flexibility to refinance maturities and deploy selectively into attractive middle‑market loans.
Bears Say
NAV DeteriorationA sizable quarter NAV markdown signals valuation and credit pressures inside the portfolio. Persistent NAV weakness can erode equity cushion, constrain dividend sustainability and limit capital-raising options, making recovery dependent on credit performance and mark-to-market stabilization over ensuing quarters.
Rising Nonaccruals & ConcentrationHigher nonaccruals, concentrated in health care and legacy CCaaS exposures, raise recovery uncertainty and potential future losses. Concentration extends resolution timelines, pressures interest income and may require reserves, affecting long-term return on invested capital until credits are resolved or recovered.
Weak Revenue Growth And Elevated Leverage RiskNegative revenue trends and volatile profitability, combined with meaningful leverage typical of a BDC, compress returns and reduce margin for error if credit conditions worsen. Elevated leverage limits flexibility for opportunistic investing and increases sensitivity of distributable income to credit losses and lower spreads.
Crescent Capital BDC News
CCAP FAQ
What was Crescent Capital Bdc, Inc.’s price range in the past 12 months?
Crescent Capital Bdc, Inc. lowest stock price was $10.92 and its highest was $16.04 in the past 12 months.
What is Crescent Capital Bdc, Inc.’s market cap?
Crescent Capital Bdc, Inc.’s market cap is $414.89M.
When is Crescent Capital Bdc, Inc.’s upcoming earnings report date?
Crescent Capital Bdc, Inc.’s upcoming earnings report date is Aug 12, 2026 which is in 57 days.
How were Crescent Capital Bdc, Inc.’s earnings last quarter?
Crescent Capital Bdc, Inc. released its earnings results on May 13, 2026. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.419 by $0.001.
Is Crescent Capital Bdc, Inc. overvalued?
According to Wall Street analysts Crescent Capital Bdc, Inc.’s price is currently Undervalued.
Does Crescent Capital Bdc, Inc. pay dividends?
Crescent Capital Bdc, Inc. pays a Notavailable dividend of $0.34 which represents an annual dividend yield of 13.2%. See more information on Crescent Capital Bdc, Inc. dividends here
What is Crescent Capital Bdc, Inc.’s EPS estimate?
Crescent Capital Bdc, Inc.’s EPS estimate is 0.37.
How many shares outstanding does Crescent Capital Bdc, Inc. have?
Crescent Capital Bdc, Inc. has 36,845,950 shares outstanding.
What happened to Crescent Capital Bdc, Inc.’s price movement after its last earnings report?
Crescent Capital Bdc, Inc. reported an EPS of $0.42 in its last earnings report, beating expectations of $0.419. Following the earnings report the stock price went down -8.262%.
Which hedge fund is a major shareholder of Crescent Capital Bdc, Inc.?
Currently, no hedge funds are holding shares in CCAP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Crescent Capital BDC Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$14.08 (3.71% Upside)
$14.08 (3.71% Upside)
Blogger Sentiment
Bullish
CCAP Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 30.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.6%
Last 30 Days ▼ 4.0%
Last 30 Days ▼ 4.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.97%
12-Months-Change
Fundamentals
Return on Equity
2.14%
Trailing 12-Months
Asset Growth
-2.93%
Trailing 12-Months
Company Description
Crescent Capital Bdc, Inc.
Crescent Capital BDC, Inc. functions as a Business Development Company (BDC), managing a fund dedicated to private equity, leveraged buyouts, and providing loan capital. The firm's strategy centers on making direct investments, with a specific focus on the middle market segment. Its investment mandate is exclusively for opportunities within the United States.
CCAP Company Deck
CCAP Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced mix of proactive, constructive strategic actions and ongoing credit challenges. Positives included permanent fee reductions to improve long-term earnings resilience, a reset dividend framework with special dividends to address spillover, solid liquidity and a robust platform pipeline, and continued portfolio-level metrics that remained largely stable (86% rated 1 or 2; interest coverage 2.2x). Offsetting these were meaningful near-term headwinds: NAV declined ~4.35% QoQ, core NII declined ~15.6% from the prior quarter (to $0.38 before the waiver), nonaccruals increased (to 5.7% of cost and 3.6% of fair value) with concentration in select health care assets, and leverage sat marginally above target. Management emphasized conservative mark-to-market practices and active portfolio management. Overall, the positives (structural fee/dividend changes, liquidity, deployment opportunities and platform strength) are balanced by credit-related pressures and earnings softness, resulting in a neutral near-term outlook but with steps aimed at longer-term stabilization.View all CCAP earnings summariesCCAP Stock 12 Month Forecast
Average Price Target
$14.08
▲(3.71% Upside)
Technical Analysis
Gladstone Capital
―
Gladstone Investment
―
Pennantpark Investment
―
BlackRock TCP Capital
―
CION Investment Corp
―
Ownership Overview
10.82% Insiders
1.06% Mutual Funds
53.52% Other Institutional Investors
30.32% Public Companies and
Individual Investors